Alcohol, Drugs, and Impaired Driving addresses many theoretical and practical issues related to the role played by alcohol and other psychoactive drugs on driving performance, road-traffic safety, and public health. Several key forensic issues are involved in the enforcement of laws regulating driving under the influence of alcohol and/or other drugs, including analytical toxicology, pharmacology of drug action, as well as the relationships between dose taken, concentration levels in the body, and impairment of performance and behavior. Our knowledge of drunken driving is much more comprehensive than drugged driving, so a large part of this book is devoted to alcohol impairment, as well as impairment caused by use of drugs other than alcohol. For convenience, the book is divided into four main sections. The first section gives some historical background about measuring alcohol in blood and breath as evidence for the prosecution of traffic offenders. The important role of the Breathalyzer instrument in traffic-law enforcement, especially in Australia, Canada, and the USA is presented along with a biographical sketch of its inventor (Professor Robert F. Borkenstein of Indiana University) with focus on the man, his work and his impact. The second section discusses several issues related to forensic blood and breath-alcohol alcohol analysis as evidence for prosecution of traffic offenders. This includes how the results should be interpreted in relation to impairment and an evaluation of common defense challenges. Because most countries have adopted concentration per se laws, the main thrust of the prosecution case is the suspect’s measured blood- or breath-alcohol concentration. This legal framework necessitates that the analytical methods used are "fit for purpose" and are subjected to rigorous quality assurance procedures. The third section gives a broad overview of the current state of knowledge about driving under the influence of non-alcohol drugs in various countries. This includes adoption of zero-tolerance laws, concentration per se statutes, and clinical evidence of driver impairment based on field sobriety tests and drug recognition expert evidence. The fourth section deals with epidemiology, enforcement, and countermeasures aimed at reducing the threat of drunken and drugged driving. All articles have appeared previously in the international journal Forensic Science Review, but all are completely updated with current data, references, and the latest research on developments since the articles were published. This book contains a convenient collection of the best articles covering recommendations for blood and breath testing methods, public policy relating to such methods, and forensic and legal implications of the enforcement of measures to counter driving under the influence.

Drugs, Driving and Traffic Safety gives a comprehensive overview of the effects of different medical conditions like neurological disorders, anxiety and depression and their pharmaceutical treatment on driving ability. In addition, the effects of alcohol and drugs of abuse are discussed. Leading experts present the different methodologies to examine effects of drugs on driving, and summarize the recent scientific evidence including epidemiological studies, roadside surveys, laboratory tests, driving simulators, and the standardized driving test. The volume includes guidelines of the International Council on Alcohol, Drugs and Traffic Safety (ICADTS) and the ICADTS Drugs List 2007. Drugs, Driving and Traffic Safety is written for physicians, psychiatrists and pharmacists who want to inform their patients who use psychoactive drugs.

This literature review provides a comprehensive report on the relationship between drug use, impaired driving and traffic accidents. It describes methodological issues (Chapter1), presents the results of prevalence surveys among drivers and provides an overview of findings from major international epidemiological surveys published since 2007 (Chapter 2) and gathers evidence from experimental and field studies of the relationship between drug use, driving impairment and traffic accidents (Chapter 3).

This is a 12-session, 24-hour education program for impaired driving offenders who have at least minimal indicators of past problems associated with AOD use or misuse and whose arrest BAC was at the impaired driving level. Level II Education helps clients to understand how problem behaviors are learned and how those behaviors are strengthened. They develop a good understanding of their involvement in impaired driving and how their state laws apply to that involvement. Clients learn how their own AOD use fits clinically identified patterns and cycles of AOD use and misuse. They develop strategies and skills to prevent future problems of use and misuse and involvement in DWI behavior: relapse and recidivism prevention.

This is a three-level education and treatment program for persons convicted of driving while impaired (DWI). Clients learn that change in behavior is made by changing their thoughts, attitudes and beliefs. The books presents a comprehensive overview of cognitive behavioral treatment for impaired driving offenders; a thorough review theory and practice related to client evaluation; legal and cultural considerations; as well as operational procedures for assessing and matching DWI offenders to appropriate levels of education and treatment services. Guidelines are provided for developing individualized treatment plans, and implementing appropriate education and treatment curriculum protocol whereby clients relate and apply the lesson and session material to their own unique circumstances and situations.